PMA device
Medtronic Minimed Continuous Glucose Monitoring System
Medtronic Minimed · Sensor, Glucose, Invasive (MDS, Class III) · First FDA decision Jun 25, 2002, newest Aug 29, 2011Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
59
Naming "Medtronic Minimed"
MAUDE reports
90
Brand "Medtronic Minimed", since 2015
PubMed studies
237
Mentioning "Medtronic Minimed"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Medtronic Minimed Continuous Glucose Monitoring System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- MEDTRONIC MINIMED CONTINUOUS GLUCOSE MONITORING SYSTEMPMA supplement
P980022-S067 · Decided Aug 29, 2011 · 602 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
- MEDTRONIC MINIMED CONTINUOUS GLUCOSE MONITORING SYSTEMPMA supplement
P980022-S023 · Decided Jul 17, 2008 · 216 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
- MEDTRONIC MINIMED CONTINUOUS GLUCOSE MONITORING SYSTEMPMA supplement
P980022-S019 · Decided Jul 11, 2007 · 124 days after receipt · Normal 180 Day Track No User Fee
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Medtronic Minimed", any status and sponsor, newest update first.
University of Colorado, DenverAcademic, hospital or other
NCT07720388 · 15 participants (planned) · Start Oct 2, 2026 · Primary completion Jul 2027
Device: Medtronic MiniMed 780G Insulin Pump System · For: Diabetes Mellitus, Type 1 Diabetes
Sites: Aurora, Colorado
- Day and Night Closed-loop in Young People With Type 1 DiabetesPivotal-lookingCompleted
Jaeb Center for Health ResearchAcademic, hospital or other
NCT02925299 · 133 participants · Start May 12, 2017 · Primary completion Aug 27, 2020
Device: FlorenceM (US) and FlorenceX (UK); Insulin pump therapy · For: Diabetes Mellitus; Diabetes Mellitus, Type 1; Glucose Metabolism Disorders and 2 more
Sites: Palo Alto, California; Aurora, Colorado; Hartford, Connecticut · 11 sites in all
- Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)Pivotal-lookingRecruiting
Medtronic MiniMed, Inc.Public (MDT)
NCT07227805 · 116 participants (planned) · Start Jul 19, 2026 · Primary completion Mar 17, 2027
Device: NMX8; 780G · For: Diabetes (Insulin-requiring, Type 1 or Type 2)
Sites: Antwerp, Belgium; Brussels, Belgium; Leuven, Belgium · 9 sites in all
56 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Medtronic Minimed", and for the whole product code for context.
This brand
90 reports: 23 malfunction, 64 injury, 2 death
Whole product code MDS
232,139 reports: 226,671 malfunction, 5,201 injury, 215 death
Newest reports for this brand
- MEDTRONIC MINIMED 780GInjury
MW5188623 · Received May 26, 2026 · Event dated May 21, 2026
Device type: Automated Insulin Dosing Device System, Single Hormonal Control (OZP)
Patient problem as coded: Hyperglycemia
- MEDTRONIC MINIMED 780GInjury
MW5187167 · Received Apr 22, 2026 · Event dated Apr 17, 2026
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG)
Patient problem as coded: Insufficient Information
- MEDTRONIC MINIMED 780G INSULIN PUMPMalfunction
MW5184464 · Received Feb 26, 2026 · Event dated Feb 3, 2026
Device type: Automated Insulin Dosing Device System, Single Hormonal Control (OZP)
Patient problem as coded: Hyperglycemia
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Paradigm REAL-Time Insulin Pump (MMT-522, MMT-722)Open, Classified
Z-1749-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
- Paradigm REAL-Time Revel Insulin Pump (MMT-523, MMT-723)Open, Classified
Z-1750-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
Z-1256-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025
Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...
Cause as FDA categorized it: Device Design · Device type: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (OYC)
11 more recall records with a free account
Published research
The most relevant PubMed records for "Medtronic Minimed"[tiab]. The summary above synthesizes these.
- Medtronic MiniMed 670G Hybrid Closed-Loop System.
Knebel T, Neumiller JJ · Clin Diabetes · 2019
- An analysis of Medtronic MiniMed 670G insulin pump use in clinical practice and the impact on glycemic control, quality of life, and compliance.
Horowitz ME, Kaye WA, Pepper GM, et al. · Diabetes Res Clin Pract · 2021
- Daytime hypoglycemic episodes during the use of an advanced hybrid closed loop system.
Rossi A, Montefusco L, Reseghetti E, et al. · Diabetes Res Clin Pract · 2023Observational Study
- Clinical Outcomes with MiniMedTM 780G Advanced Hybrid Closed-Loop Therapy in 2- to 6-Year-Old Children with Type 1 Diabetes.
Abraham MB, Smith GJ, Dart J, et al. · Diabetes Technol Ther · 2024Research Support, Non-U.S. Gov't
- In vitro Stability of Biosimilar Insulin Aspart SAR341402 in the Medtronic MiniMed Insulin Pumps.
Mohnicke M, Blecher A, Beichert K, et al. · J Pharm Sci · 2023Research Support, Non-U.S. Gov't
- Patent analysis of digital sensors for continuous glucose monitoring.
Litvinova O, Eitenberger M, Bilir A, et al. · Front Public Health · 2023Review, Research Support, Non-U.S. Gov't
- Commercialized Hybrid Closed-Loop System (Minimed Medtronic 670G) Results During Pregnancy.
Moreno-Fernández J, García-Seco JA · AACE Clin Case Rep · 2021Case Reports
- Safety, metabolic and psychological outcomes of Medtronic MiniMed 670G in children, adolescents and young adults: a systematic review.
Mameli C, Smylie GM, Galati A, et al. · Eur J Pediatr · 2023Systematic Review
- Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes.
Dadlani V, Pinsker JE, Dassau E, et al. · Curr Diab Rep · 2018Review
- Impact of Missed and Late Meal Boluses on Glycemic Outcomes in Automated Insulin Delivery-Treated Children and Adolescents with Type 1 Diabetes: A Two-Center, Population-Based Cohort Study.
Laugesen C, Ritschel T, Ranjan AG, et al. · Diabetes Technol Ther · 2024Multicenter Study, Research Support, Non-U.S. Gov't
- Safety, Metabolic and Psychological Outcomes of Medtronic MiniMed 780Gࡊ in Children, Adolescents and Young Adults: A Systematic Review.
Passanisi S, Lombardo F, Mameli C, et al. · Diabetes Ther · 2024Review
- Carbohydrate Tolerance Threshold for Unannounced Snacks in Children and Adolescents With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System.
Tornese G, Carletti C, Giangreco M, et al. · Diabetes Care · 2022Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code MDS.
- Dexcom G4 Platinum Continuous Glucose Monitoring System and Dexcom 5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2018
- G5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2024
- FreeStyle Libre Pro Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc. · PMA 2020
- Freestyle Navigator Continuous Glucose Monitoring SystemAbbott Laboratories · PMA 2011
- Paradigm Real-Time Insulin PumpMedtronic Minimed · PMA 2015
- Guardian Connect SystemMedtronic Minimed · PMA 2025
- Dexcom Seven SystemDexcom, Inc. · PMA 2009
- Guardian RtMedtronic Minimed · PMA 2006
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.